MassVentures

Minutes

MassVentures Board Meeting

Date and Time

Thursday October 13, 2022 at 8:00 AM

Location

308 Congress Street (if in person)
Join Zoom Meeting

 

Meeting ID: 840-0424-4492
Password: 8792

 

Dial by your location
     (312) 626 6799 (Chicago)

 

Directors Present

C. Bouthot (remote), D. Schultheis (remote), J. Griffin (remote), J. Hoch (remote), J. O'Reilly (remote), M. Attia (remote), M. Fuller (remote), M. James (remote), M. Valanzola (remote), R. Jarquin (remote), W. Asher (remote)

Directors Absent

None

Guests Present

C. Hipwood, J. Madison, M. Wilcox, P. Yadav, S. Leis, S. Swider, V. Nijhawan

I. Opening Items

A.

Call the Meeting to Order

M. Fuller called a meeting of the board of directors of MassVentures to order on Thursday Oct 13, 2022 at 8:01 AM.

B.

Intro - Mark Fuller

Mr. Fuller introduced himself as the new designee of Secretary Kennealy.  

C.

Examples of Mission

Mr. Hipwood provided several examples of staff working towards the mission.  

D.

Highlights

Mr. Hipwood presented several highlights since the last meeting.

E.

Audit Presentation

Auditors from Katz, Nannis and Solomon, Jeff Solomon and Sarah Pratt, provided an overview of the MassVentures' audit process.  Additionally, they presented an overview of the financials.  Discussion ensued.   It was noted that management was cooperative with the audit and there were no material findings to report. 

II. Approvals

A.

Board Minutes

W. Asher made a motion to approve the minutes from MassVentures Board Meeting on 09-08-22.
R. Jarquin seconded the motion.
The board VOTED to approve the motion.
Roll Call
M. Valanzola
Aye
J. Griffin
Aye
W. Asher
Aye
M. Attia
Aye
C. Bouthot
Aye
J. Hoch
Abstain
D. Schultheis
Aye
M. Fuller
Abstain
M. James
Aye
R. Jarquin
Aye
J. O'Reilly
Aye

B.

Pre-investment action sheet - InGel Therapeutics

J. O'Reilly made a motion to Approve the pre-investment action sheet for InGel Therapeutics.
M. Valanzola seconded the motion.
The board VOTED to approve the motion.
Roll Call
J. Hoch
Abstain
M. Attia
Aye
M. Fuller
Abstain
R. Jarquin
Aye
J. O'Reilly
Aye
J. Griffin
Aye
M. James
Aye
W. Asher
Aye
D. Schultheis
Aye
M. Valanzola
Aye
C. Bouthot
Aye

C.

Audit Committee Minutes - October 12, 2022

W. Asher made a motion to approve the audit report and minutes as presented Audit Committee Meeting on 10-12-22.
M. Attia seconded the motion.
The board VOTED to approve the motion.
Roll Call
J. O'Reilly
Aye
M. Fuller
Abstain
M. Attia
Aye
W. Asher
Aye
M. Valanzola
Aye
C. Bouthot
Aye
M. James
Aye
D. Schultheis
Aye
R. Jarquin
Aye
J. Hoch
Aye
J. Griffin
Aye

III. Financial Matters

A.

Treasurer's Report

Mr. Madison presented the treasurer's report for July and August 2022.  Discussion ensued.

B.

Approve Treasurer's Report

J. Griffin made a motion to Accept the treasurer's report as presented.
W. Asher seconded the motion.
The board VOTED to approve the motion.
Roll Call
C. Bouthot
Aye
J. O'Reilly
Aye
M. James
Aye
M. Attia
Aye
J. Hoch
Aye
M. Fuller
Aye
R. Jarquin
Aye
M. Valanzola
Aye
D. Schultheis
Aye
W. Asher
Aye
J. Griffin
Aye

IV. Conflicts of Interest

A.

Conflicts

Mr. Hipwood presented a list of new companies in the pipeline for potential funding and ask the board to declare any conflicts of interest.  None were declared.  

V. President's Report

A.

General Update

Mr. Hipwood provided a general update on the business.  

B.

MV Capital Update

MassVentures' staff provided updates on the various MV Capital programs.  

C.

MV Accelerate Update

MassVentures' staff provided updates on the various MV Accelerate programs.  

D.

Other Updates

VI. Executive Session

A.

Roll Call Vote to Enter Executive Session

W. Asher made a motion to Enter executive session to discuss confidential information related to applicants of MassVentures funds as well as compensation matters related to MassVentures' employees.
R. Jarquin seconded the motion.
The board VOTED to approve the motion.
Roll Call
M. Fuller
Aye
J. O'Reilly
Aye
C. Bouthot
Aye
J. Hoch
Aye
R. Jarquin
Aye
J. Griffin
Aye
M. Attia
Aye
M. Valanzola
Aye
D. Schultheis
Aye
W. Asher
Aye
M. James
Aye

B.

Pipeline Report

C.

Portfolio Update

MassVentures' staff provided updates on the portfolio companies.  Discussion ensued.  

D.

MassVentures' staff left the meeting in advance of the Comp Committee presentation

In executive session, and in advance of the Comp Committee discussion on compensation matters, all staff members, with the exception of Mr. Hipwood, left the meeting

E.

Comp Committee Minutes - October 5, 2022

M. Fuller made a motion to approve the minutes from Compensation Committee on 10-05-22.
R. Jarquin seconded the motion.
The board VOTED to approve the motion.
Roll Call
M. Valanzola
Aye
W. Asher
Abstain
C. Bouthot
Abstain
M. James
Aye
J. Hoch
Abstain
D. Schultheis
Abstain
M. Attia
Abstain
M. Fuller
Aye
J. Griffin
Aye
J. O'Reilly
Abstain
R. Jarquin
Aye

F.

Comp Committee Minutes - October 11, 2022

M. Valanzola made a motion to approve the minutes from Compensation Committee on 10-11-22.
J. Griffin seconded the motion.
The board VOTED to approve the motion.
Roll Call
W. Asher
Aye
M. James
Aye
M. Fuller
Aye
C. Bouthot
Abstain
J. Hoch
Abstain
J. O'Reilly
Abstain
R. Jarquin
Aye
J. Griffin
Aye
M. Attia
Abstain
M. Valanzola
Aye
D. Schultheis
Abstain

G.

Approval of Report of Comp Committee and acceptance of Comp Committee minutes

R. Jarquin made a motion to Approve the report of the comp committee and acceptance of the comp committee minutes.
D. Schultheis seconded the motion.
The board VOTED to approve the motion.
Roll Call
C. Bouthot
Aye
M. James
Absent
W. Asher
Aye
M. Valanzola
Aye
M. Fuller
Aye
D. Schultheis
Aye
J. Griffin
Aye
J. Hoch
Aye
M. Attia
Abstain
R. Jarquin
Aye
J. O'Reilly
Aye

Mr. Hipwood left the meeting

H.

Vote on any changes to Compensation Structure for Fiscal Year 2023

M. Valanzola made a motion to Approve FY 2023 base compensation and variable compensation recommended by Compensation Committee:.
W. Asher seconded the motion.
The board VOTED to approve the motion.
Roll Call
J. Griffin
Aye
W. Asher
Aye
M. James
Absent
M. Fuller
Aye
D. Schultheis
Aye
M. Valanzola
Aye
R. Jarquin
Aye
J. O'Reilly
Aye
C. Bouthot
Aye
M. Attia
Abstain
J. Hoch
Abstain

The board considered the desirability of extending the term of Mr. Hipwood’s employment contract beyond its June 2023 expiration date.  It was the consensus of the board to support an extension and that a proposal should be considered at the next board meeting.

I.

Comp Committee Presentation for staff base and variable compensation

Mr. Fuller presented the staff base and variable compensation schedule for fiscal 2023 recommended by the Compensation Committee.  He explained that the revised approach is intended to (i) reset overall base compensation levels and align variable compensation with other quasi state entities and (ii) determine specific key performance indicators for variable compensation (to be proposed at the next board meeting). Consideration of a possible “carried interest” bonus for realized investment gains was deferred to a later time. Discussion ensued.

VII. Closing Items

A.

Adjourn Meeting

There being no further business to be transacted, and upon motion duly made, seconded and approved, the meeting was adjourned at 9:50 AM.

Respectfully Submitted,
W. Asher